Sanofi Non-GAAP EPS of €1.71 in-line, revenue of €10.72B misses by €260M; initiates FY23

[ad_1] Full-year 2023 business EPS guidance: Sanofi expects 2023 business EPS to grow low single digit at CER, barring unforeseen major adverse events. Applying average January 2023 exchange rates, the currency impact on 2023 business EPS is estimated between -3.5% to -4.5%. [ad_2] Source link